Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Settlement is final.

The next step:

If the J3 are now with TPL/PTSC for the '584 Appeal, might it not then follow that such a scenario would make it so much easier to persuade ARM not only to reach a stipulated decision as to the legal definition(Markman) of the current term under appeal, but more importantly to get some fees from ARM: $x for past infringement/license, PLUS y% of every chip sold going forward(Gross reported revenue). Remember, a PATENT trumps a COPYRIGHT every time.

This would release ARM from any liability to their customers and give PTSC a continuing revenue stream until patent expiry.

Both sides could be "pleased" with the resolution of their differences.

A non-financial result has become a financial result and PTSC was fully compliant in reporting for the recent Q filing.

Be well

Share
New Message
Please login to post a reply